Is a complete TTRX research report available?

No complete published report is available for Turn Therapeutics Inc. (TTRX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Turn Therapeutics Inc. (TTRX)

NASDAQ: TTRX · USD

$8.54

-0.94 (-9.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TTRX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	254.4M
Net income (ttm)	-3.8M
EPS (ttm)	-$0.14
Shares out	29.8M
Volume	99,619

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -3.8M
EPS (ttm): -$0.14
Market cap: 254.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TTRX indicators

Market & fundamental data

Available fields

145

Groups with data

Currency

USD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002023016
Company name	Turn Therapeutics Inc.
Country	United States
Country code	US
Cusip	90021W105
Employees	2
Employees Change	-2%
Employees Change Percent	-50
Enterprise value	$249.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US90021W1053
Last refreshed	2026-07-27
Market cap	$254.4M
Market cap category	Micro-Cap
Price	$8.54
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	TTRX
Website	https://turntherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.51%
P/B ratio	41.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-974,595
Net Income	$-3.8M
Net Income Growth Years	0%
Profit Per Employee	$-1.9M
ROCE	-49.73
ROE	-129.2
ROIC	-79.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$18.6M
Cash	$11.2M
Current Assets	$11.5M
Current Liabilities	$5.1M
Debt	$6M
Debt Equity	$0.98
Equity	$6.1M
Liabilities	$12.5M
Long Term Assets	$7.2M
Long Term Liabilities	$7.4M
Net Cash	$5.2M
Net Cash By Market Cap	$2.05
Net Cash Growth	593.46%
Net Debt Equity	$-0.85
Tangible Book Value	$5.2M
Tangible Book Value Per Share	$0.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.23
Net Working Capital	$-4.8M
Quick ratio	2.19
Working Capital	$6.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.93%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	6.78
All Time High	26.5
All Time High Change	-67.77%
All Time High Date	2025-10-09
All Time Low	2.57
All Time Low Change	232.3%
All Time Low Date	2025-11-20
ATR	0.9
Beta1y	0.09
Ch YTD	116.8
High	9.81
High52	26.5
High52 Date	2025-10-09
High52ch	-67.77%
Low	8.5
Low52	2.57
Low52 Date	2025-11-20
Low52ch	232.3%
Ma50ch	25.96%
RSI	52.67
RSI Monthly	0
RSI Weekly	69.72
Sharpe ratio	0.73x
Sortino ratio	1.28
Total Return	-5.93%
Tr YTD	116.8
Tr1m	42.57%
Tr1w	-6.36%
Tr3m	154.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.02
Operating Income	$-7.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,828,428%
Float Percent	36.35%
Net Borrowing	6,716,561
Shares Insiders	58.79%
Shares Institutions	2.68%
Shares Out	29,788,040
Shares Qo Q	3.69%
Shares Yo Y	5.93%
Short Float	0.36%
Short Ratio	0.65
Short Shares	0.13

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	134,175.5x
Bv Per Share	0.21
Ch1m	42.57
Ch1w	-6.36
Ch3m	154.9
Ch6m	75.72
Change	-9.92%
Change From Open	-11.59
Close	9.48
Days Gap	1.9
Depreciation Amortization	54,775
Dollar Volume	850,746.3
Earnings Date	2026-08-10
Earnings Time	amc
EBIT	$-6.7M
EBITDA	$-6.7M
EPS	$-0.14
F Score	0
Financing CF	13,707,901
Fiscal Year End	December
Founded	2,015
Investing CF	-165,213
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-31
Ma150	4.74
Ma150ch	80.21%
Ma20	8.73
Ma20ch	-2.21%
Net CF	9,645,038
Next Earnings Date	2026-08-10
Open	9.66
Optionable	No
Position In Range	3.05
Ppne	67,573
Price Date	2026-07-24
Ptbv Ratio	48.94
Relative Volume	0.74x
Share Based Comp	623,478
Tr6m	75.72%
Us State	California
Volume	99,619

Turn Therapeutics Inc. (TTRX)

Coverage state: Market snapshot only — no published research

Generate the first TTRX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · TTRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TTRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TTRX

Frequently asked questions